login
  Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 

Debate: Fixed vs. mobile hybrid operating rooms


Friday, 24 Jun 2011 12:24
OEC 9900 Elite MD
OEC 9900 Elite MD


Marc Bosiers, Dendermonde, Belgium, and Stéphan Haulon Lille, France, debated on the use of fixed vs. mobile hybrid operating rooms for endovascular procedures at the CX Vascular Imaging Course 2011 (London, UK). 


Bosiers said that a hybrid suite with a flat panel fixed lab compared to a traditional suite brings higher quality to both percutaneous interventions and surgery. “In a fixed hybrid suite, the positioning of the table presents no disturbance from the C-arm. The offset arm allows flexible patient access during endovascular procedures and groin coverage.” Bosiers also noted that in fixed hybrid rooms the rotational imaging over 200°, the imaging acquisition time in 5, 10 or 20 seconds, the provision of 30 images per second and 3D reconstruction in 20 seconds allow perfect imaging.

 

“In fixed hybrid rooms the rotational imaging (GE Healthcare) facilitates intra-operative selection of branched and fenestrated stent grafts. It also allows both vascular imaging (vessel lumen and plaque) and visualisation of soft tissues,” Bosiers commented.

 

In terms of the operation room environment, Bosiers said, “A floor mounted system keeps the ceiling clear, which permits no interference with monitor access for any approach.” It is easy to clean and it does not have interference with laminar air flow or passing over the sterile field, he added. 

 

Stéphan Haulon, chief of Vascular Surgery Hôpital Cardiologique – CHRU, Lille, France, favoured the use of mobile hybrid operating rooms. Haulon presented the OEC 9900 Elite MD (GE Healthcare) as an example of a mobile operating room which can be acquired at a lower cost compared to fixed hybrid operating rooms. The OEC 9900 Elite MD raises the mobile C-arm standard with a motorised C-arm. “It allows left and right patient access providing complete control of lateral and orbital C-arm movements for patient safety,” Haulon commented. “Everything can be performed with a table side control panel. I can control the whole set up myself. I can decide exactly the angulation that I need and I can see exactly the level in which I am with the floating table.” The control panel also contains diverse and easily adjustable dose settings which facilitate mask selection for fluoro roadmap, he said. “I think the motorisation is the key to success on performing complex endovascular aortic repairs,” Haulon stated. “In combination with the motorised system, the floating table helps you to shrink the overall operative time in between cases, I do not need to change table because I can perform all my open surgery and all my endovascular surgery on the same table...Now, from a regular EVAR it takes between 45 minutes to one hour, before it used to take almost one hour and a half,” he aded.

 

“The OEC 9900 Elite MD has a specific cooling system. I never have to stop because of over heating, even in complex procedures. It is a very safe and fast system, and it is very convenient for all the staff in the operating room,” Haulon concluded.

 




Add New Comment

Most popular


Incraft low-profile endograft launched in Europe and Canada
Wednesday, 10 Sep 2014
Cordis announced on 10 September the launch of its Incraft AAA Stent Graft System, an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from ... Incraft low-profile endograft launched in Europe and Canada

First patient enrolled in US study of Novate’s Sentry IVC filter
Monday, 22 Sep 2014
Novate Medical has announced that Souheil Saddekni, professor of Vascular and Interventional Radiology at the University of Alabama, Birmingham, USA, has enrolled the first patient in the SENTRY IDE ... First patient enrolled in US study of Novate’s Sentry IVC filter

First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

Features


Not all drug-eluting balloons are equal
Wednesday, 15 Oct 2014
Thomas Zeller, Bad Krozingen, Germany, analyses the results of two recent randomised controlled trials comparing drug-eluting balloons to angioplasty alone in femoropopliteal lesions. Not all drug-eluting balloons are equal

Renal stenting may benefit patients excluded from randomised trials, says expert consensus
Wednesday, 15 Oct 2014
Sahil A Parikh, Case Western Reserve University School of Medicine, Cleveland, USA, speaks to Vascular News about the Society for Cardiovascular Angiography and Interventions expert consensus on ... Renal stenting may benefit patients excluded from randomised trials, says expert consensus

Profiles


Martin Björck
Wednesday, 01 Oct 2014
Martin Björck, Uppsala University Hospital, Sweden, holds the only professor-chair of vascular ... Martin Björck

Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions